Inovalon has agreed to acquire DrFirst, according to a LinkedIn post from Inovalon dated November 12, 2026. The post describes the transaction as a definitive agreement. The purchase price was not disclosed in the source.
DrFirst brings prescribing, prior authorization, benefit determination and patient communications offerings to the combination, according to the post. Inovalon said the deal will extend its product reach into clinical workflows.
The post frames the rationale around the steps that follow a prescription, from coverage questions to prior authorizations to pharmacy callbacks, which it says can delay the start of treatment for patients. According to the post, the combined companies intend to put richer information and intelligent decision support directly into the workflows where healthcare decisions are being made, and to bring more resources to help patients get their medications and stay on them.
The post also said Inovalon looks forward to welcoming the DrFirst team. No closing date, financing details or advisers were disclosed in the source.